↑ 薬物リストへ　← 戻る

Cx516 (ampalex®)    (DrugBank: CX516)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
206脆弱X症候群1

206. 脆弱X症候群　［臨床試験数：98，薬物数：73（DrugBank：27），標的遺伝子数：46，標的パスウェイ数：57］
Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 98 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00054730
(ClinicalTrials.gov)		June 20027/2/2003Effects of CX516 on Functioning in Fragile X Syndrome and AutismEffects of Ampakine CX516 (Ampalex®) on Functioning in Fragile X Syndrome and AutismFragile X Syndrome;AutismDrug: CX516 (Ampalex®)Cortex PharmaceuticalsFRAXA FoundationCompleted18 Years50 YearsBothPhase 2United States